Prothena | PRTA - الدين





الدين تغيير تاريخ
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 70M 1.6M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amgen USD 54.6B 17M 2025-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 605.86M 1.62M 2025-12
Exelixis USD 173.04M 3.42M 2025-12
Immunic USD 0 0 2024-06
Incyte USD 39.43M 982K 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
MacroGenics USD 37.01M 238K 2025-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 415.3M 13.1M 2025-12
Prothena USD 9.08M 699K 2025-09
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 2.03B 195.7M 2025-12
Xoma USD 120.79M 3.27M 2024-06